HealthStream director proposes $106K share sale
Raymond James & Associates is identified as the broker, and the notice lists two restricted-share-unit acquisition dates in 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HealthStream, Inc. director Deborah Taylor Tate reported a proposed sale of 3,281 shares of common stock through Raymond James & Associates, Inc., with an aggregate market value of $106,000.00 and an approximate sale date of November 5, 2026. The securities details list 1,149 shares acquired as restricted share units on March 27, 2025, and 2,132 shares acquired as restricted share units on June 6, 2025.
Key Figures
Key Terms
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.